enzymatic degradation of protein antigens by endo-lysosomal proteases in antigen-presenting cells is crucial for achieving cellular immunity. Structural changes caused by vaccine production process steps, such as formaldehyde inactivation, could affect the sensitivity of the antigen to lysosomal proteases. The aim of this study was to assess the effect of the formaldehyde detoxification process on the enzymatic proteolysis of antigens by studying model proteins. Bovine serum albumin, β-lactoglobulin A and cytochrome c were treated with various concentrations of isotopically labelled formaldehyde and glycine, and subjected to proteolytic digestion by cathepsin S, an important endo-lysosomal endoprotease. Degradation products were analysed by mass spectrometry and size exclusion chromatography. The most abundant modification sites were identified by their characteristic MS doublets. Unexpectedly, all studied proteins showed faster proteolytic degradation upon treatment with higher formaldehyde concentrations. This effect was observed both in the absence and presence of glycine, an often-used excipient during inactivation to prevent intermolecular crosslinking. Overall, subjecting proteins to formaldehyde or formaldehyde/glycine treatment results in changes in proteolysis rates, leading to an enhanced degradation speed. This accelerated degradation could have consequences for the immunogenicity and the efficacy of vaccine products containing formaldehydeinactivated antigens. Enzymatic degradation of antigens is a crucial step in the process of acquiring cellular immunity, e.g., through the induction of antigen specific T-helper cells or cytotoxic T-cells. The endo-lysosomal protease activity is lower for immune cells with high antigen presentation capacity, such as dendritic cells, than for cells with lower antigen presentation capacity, such as neutrophils. 1 Several groups have found a correlation between slow proteolytic antigen degradation and increased immunogenicity of the studied antigen, 2-9 although it does not hold up for all antigens. 10 This correlation suggests that protease resistance could be an important factor for vaccine efficacy. Currently numerous efforts are being made to replace, reduce and refine (3Rs) the use of animal tests. 11,12 One approach to achieve this is the so-called consistency approach. 13 This approach is based on the principle that if a panel of in-vitro tests can prove that a vaccine product is produced in a consistent manner, reduction or replacement of quality control animal tests is possible. An in-vitro test that could follow changes in enzymatic degradation kinetics of protein antigens may thus be used to monitor vaccine batch quality in a consistency approach. Many antigens in inactivated vaccine products, such as bacterial toxins and poliovirus, are inactivated by using a mixture of formaldehyde and amino acids. This treatment results in modifications to the protein, as reported previously by Metz et al. (Table 1. 14,15 These modifications may alter the immunogenicity of...